Skip to main content
Recall Canary
Amlodipine and Olmesartan Medoxomil Tablets
← Back to all recalls
DRUG RECALLMODERATE

Amlodipine and Olmesartan Medoxomil Tablets

Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets (10 mg/20 mg) due to failed dissolution specifications.

What to do

Contact your healthcare provider or pharmacist to discuss alternative treatment options. Do not stop taking your medication without consulting a medical professional.

Posted
Updated
Agency
Firm
Ascend Laboratories, LLC
Recall ID
99385
Status
ONGOING

Why it was recalled

Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets due to failed dissolution specifications and Olmesartan Medoxomil content that is below required specifications. This recall affects the 10 mg/20 mg strength in 30-count bottles.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Amlodipine and Olmesartan Medoxomil Tablets

Strength
10 mg
NDC / UPC
NDC 67877-500-30

Other recent recalls from Ascend Laboratories, LLC

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-07-21 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification